Skyward Specialty Insurance Group (NASDAQ:SKWD) Price Target Raised to $44.00 at Keefe, Bruyette & Woods

Skyward Specialty Insurance Group (NASDAQ:SKWD - Free Report) had its price target raised by Keefe, Bruyette & Woods from $43.00 to $44.00 in a research note published on Wednesday, Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the stock.

Several other brokerages also recently commented on SKWD. Raymond James raised their target price on Skyward Specialty Insurance Group from $36.00 to $40.00 and gave the stock a strong-buy rating in a research note on Tuesday, December 12th. BMO Capital Markets raised their target price on Skyward Specialty Insurance Group from $31.00 to $37.00 and gave the stock a market perform rating in a research note on Monday, February 26th. Wolfe Research initiated coverage on Skyward Specialty Insurance Group in a research note on Thursday, January 11th. They issued an outperform rating and a $39.00 target price for the company. Piper Sandler raised their target price on Skyward Specialty Insurance Group from $43.00 to $46.00 and gave the stock an overweight rating in a research note on Monday, April 1st. Finally, JMP Securities raised their target price on Skyward Specialty Insurance Group from $38.00 to $40.00 and gave the stock a market outperform rating in a research note on Wednesday, February 21st. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of Buy and a consensus target price of $39.67.

Skyward Specialty Insurance Group Stock Down 2.4 %

SKWD traded down $0.92 during trading hours on Wednesday, hitting $36.66. The stock had a trading volume of 224,661 shares, compared to its average volume of 318,612. The company's fifty day simple moving average is $35.09 and its 200 day simple moving average is $32.47. Skyward Specialty Insurance Group has a 1 year low of $20.63 and a 1 year high of $38.64. The stock has a market cap of $1.47 billion, a PE ratio of 16.37 and a beta of 0.45.

Skyward Specialty Insurance Group (NASDAQ:SKWD - Get Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.05. Skyward Specialty Insurance Group had a return on equity of 14.31% and a net margin of 9.56%. The company had revenue of $321.60 million during the quarter, compared to analyst estimates of $320.34 million. During the same quarter last year, the firm posted $0.36 EPS. The firm's revenue for the quarter was up 21.5% on a year-over-year basis. As a group, equities analysts expect that Skyward Specialty Insurance Group will post 2.63 EPS for the current year.

Insider Activity

In other Skyward Specialty Insurance Group news, CEO Andrew S. Robinson sold 13,374 shares of the company's stock in a transaction that occurred on Wednesday, March 6th. The stock was sold at an average price of $35.70, for a total value of $477,451.80. Following the completion of the sale, the chief executive officer now owns 96,883 shares of the company's stock, valued at $3,458,723.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Skyward Specialty Insurance Group news, CEO Andrew S. Robinson sold 13,374 shares of the company's stock in a transaction that occurred on Wednesday, March 6th. The stock was sold at an average price of $35.70, for a total value of $477,451.80. Following the completion of the sale, the chief executive officer now owns 96,883 shares of the company's stock, valued at $3,458,723.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Mark W. Haushill sold 25,000 shares of the company's stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $35.58, for a total value of $889,500.00. Following the completion of the sale, the chief financial officer now directly owns 236,688 shares of the company's stock, valued at approximately $8,421,359.04. The disclosure for this sale can be found here. In the last 90 days, insiders sold 98,890 shares of company stock worth $3,533,839.

Institutional Trading of Skyward Specialty Insurance Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP boosted its stake in Skyward Specialty Insurance Group by 87.9% in the fourth quarter. Quarry LP now owns 746 shares of the company's stock worth $25,000 after buying an additional 349 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Skyward Specialty Insurance Group by 390.8% in the second quarter. Tower Research Capital LLC TRC now owns 2,032 shares of the company's stock valued at $52,000 after purchasing an additional 1,618 shares during the last quarter. Amalgamated Bank lifted its position in Skyward Specialty Insurance Group by 90.9% in the third quarter. Amalgamated Bank now owns 2,300 shares of the company's stock valued at $63,000 after purchasing an additional 1,095 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Skyward Specialty Insurance Group by 54.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,362 shares of the company's stock valued at $114,000 after purchasing an additional 1,186 shares during the last quarter. Finally, Citigroup Inc. bought a new stake in Skyward Specialty Insurance Group in the second quarter valued at approximately $87,000. Hedge funds and other institutional investors own 94.83% of the company's stock.

About Skyward Specialty Insurance Group

Skyward Specialty Insurance Group, Inc, an insurance holding company, underwrites commercial property and casualty insurance products in the United States. It offers general liability, excess liability, professional liability, commercial auto, group accident and health, property, surety, and workers' compensation insurance products.